The specific degradation rate for BPC-157 in capsule matrix under retail storage conditions has not been published
There are ample studies on the efficacy of GLP-1 agonists and lifestyle changes in helping people to lose weight, with outcomes that range from 10 pounds to 33 pounds or more
There can be an average weight loss of around 4 lbs over 3 months, though results can vary depending on starting weight, diet, physical activity, and underlying metabolic health
Your provider should track fasting glucose, HbA1c, blood pressure, lipid panels, and inflammatory markers throughout the treatment course
She was not involved in the study but is on Novo Nordisks scientific advisory board
And I think thats why everyone on the team needs to be thinking about this as a part of the puzzle, because these medications are very popular and widespread use